“What is treatment resistance in Psychiatry?”

The above editorial “What is treatment resistance in Psychiatry?” features in the current edition of World Psychiatry and has generated considerable discussion on social media. Ten months ago this “News” … Continue reading “What is treatment resistance in Psychiatry?”

Values

The following film is an expression of my reasons for having resigned from the Royal College of Psychiatrists. I took this decision after a lot of reflection about what is … Continue reading Values

“This unique event will bring together world leaders in research on depression”

This event hosted by the Royal Society of Medicine will take place at 1 Wimpole Street, London on the 29th January 2019. It has been approved for 6 CPD points. … Continue reading “This unique event will bring together world leaders in research on depression”

Sunshine legislation

I have just sent this letter: Sent: 07 October 2018 10:49 Subject: Sunshine legislation Bridge of Allan, 7th October 2018 Dear Royal Colleges, General Medical Council, UK Governments, UK Parliaments/Assemblies, … Continue reading Sunshine legislation

Professor Anthony Cleare

This is my latest post as part of a series reporting the available information on competing financial interests in ‘key opinion leaders’ in British psychiatry. This is Professor Anthony Cleare’s … Continue reading Professor Anthony Cleare

The [generally hidden] place of big business . . .

I am a celebrant of subjectivity and a seeker of objectivity. I share here [the generally hidden] commercial influences of ‘key opinion leaders’ in British Psychiatry:

British Association for Psychopharmacology Guidelines (BAP)

The above Evidence-based guidelines for treating depressive disorders with antidepressants have recently been published. The British Association for Psychopharmacology are an organisation highly regarded by my profession of psychiatry. 12% of their … Continue reading British Association for Psychopharmacology Guidelines (BAP)